Scientist.com

In 2024, the biotherapeutics industry made significant progress in transforming disease treatment. Dr. Francisca Neethling, Head of Biotherapeutic Services at Eurofins Discovery, shares the highs and lows of the past year, what to expect in 2025 & more: app.scientist.com/blog/2024/12/1…

NEW PODCAST EPISODE 🎙️ Drs. Bas Trietsch from @MIMETAS and Jenna Moccia from @STEMCELLTech explore the use of stem cell-based models in drug discovery. Listen or read the summary, here : insidescientific.com/industry-insig…

"Make genome editing easier" is the goal of @Ubigene. How are their products and services making this a reality? Find out in our latest edition of Supplier Spotlight®: app.scientist.com/blog/2024/12/0…

Get to know Indivumed Services in this latest edition of Supplier Spotlight®. We asked them about their service offerings, what problems they help solve, new product and service developments & more. Read the full blog post now: app.scientist.com/blog/2024/12/0… @CrownBioscience

Introducing Tissue 2 Target, a one-stop service wherein you can procure high-quality, well-characterized human biospecimens and obtain advanced genomic analysis of the samples seamlessly and effectively. @cureline_inc @cellecta Learn more, here: app.scientist.com/blog/2024/12/0…

Epigenomics is rapidly gaining recognition as a crucial approach in the field of cancer research. Learn how @Diagenode contributed their two decades of epigenomic knowledge to developing an early-detection workflow for colorectal cancer (CRC). Read more: app.scientist.com/blog/2024/11/2…

Recently in Nature, Andrew Bradbury & Andreas Plückthun call for a shift in standard research methods toward the use of properly validated, recombinant protein binding reagents. That's where @MiltenyiBiotec comes in. Learn about their REAfinity Antibodies: app.scientist.com/blog/2024/11/2…

Cell viability is an essential measurement in research areas like drug discovery, toxicology, cancer biology and immunotherapy. In this blog post, @BPSBioscience shares what factors to consider when choosing a viability assay and more! Read it here: app.scientist.com/blog/2024/11/2…

We are proud to announce that our Founder and CEO, Kevin Lustig, has been included on the SD500 list of "The Most Influential People in San Diego" 👏 Thank you to @SDBusiness for the recognition, and congratulations to everyone that made it on the list! sdbj.com

Immune checkpoint inhibitors (ICIs) have revolutionized treatment for advanced solid tumors, but several challenges persist. Learn how antibody arrays are showing great potential for advancing precision medicine in ICI therapy, here: app.scientist.com/blog/2024/11/1… @RayBiotech:

Dive into our latest blog post to learn more about how Peripheral Blood Mononuclear Cells (PBMCs) are isolated and analyzed by Mediford Corporation so they can be utilized for immunology research and vaccine development: app.scientist.com/blog/2024/11/1…

To be humanized or not to be? That is the question... In today's blog, AvantGen discusses how camelid antibodies have emerged as an exciting alternative for antibody therapeutics, their distinct advantages, whether or not humanization is necessary & more: app.scientist.com/blog/2024/11/1…

Honoring the courage, dedication & sacrifice of the veterans who have served our country & continue to inspire us every day. We are proud to have such incredible individuals as part of our team here at Scientist.com! Happy #VeteransDay2024! 🇺🇸

Another R&D Vendor Discovery Day is officially in the books! It was a fantastic experience fostering connections and networking with fellow professionals in the life sciences. A big thank you to all the vendors and researchers who joined us today.

This on-demand webinar with @ionoptix presents the cardiac slice model for examining myocardial function and showcases techniques and results from a cardiomyopathy mouse model 🫀 Access the recording now: bit.ly/4gCike4

Scientist.com dressed to impress this Halloween 🎃 From Waldo to Wordle, we've got it all! Happy Halloween!

We're thrilled to announce that Scientist.com has been named the 3rd fastest-growing private company in the large company category by @SDBusiness! This recognition is a testament to the hard work & dedication of our incredible team over the years.sdbj.com/?oly_enc_id=35…

On the blog today, @CrownBioscience shares how leveraging PDX models in mouse clinical trials can help researchers dramatically improve the predictability of clinical outcomes, identify actionable biomarkers & better stratify patient populations: app.scientist.com/blog/2024/10/2…

Using CRISPR for genome editing presents challenges, such as efficiently delivering #CRISPR components into the cell nucleus, avoiding random vector integration, etc. In our latest blog with @Cytosurge, we discuss how CellEDIT addresses these issues: app.scientist.com/blog/2024/10/1…

We had the pleasure of talking with @DrHelenECollin1 about her research on the mechanisms contributing to female cardiovascular health and resilience in the setting of physiological and pathological stressors. View the interview or listen to the podcast: insidescientific.com/talking-real-s…